Haleon (NYSE:HLN) Upgraded at Hsbc Global Res

Hsbc Global Res upgraded shares of Haleon (NYSE:HLN) from a hold rating to a strong-buy rating in a research report released on Wednesday morning,Zacks.com reports.

A number of other research analysts also recently commented on HLN. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Haleon in a research note on Wednesday, October 8th. Jefferies Financial Group restated a “buy” rating on shares of Haleon in a report on Tuesday. Morgan Stanley reaffirmed an “overweight” rating on shares of Haleon in a research report on Monday, December 15th. Finally, Deutsche Bank Aktiengesellschaft lowered shares of Haleon from a “hold” rating to a “sell” rating in a report on Monday, January 12th. One analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating, three have assigned a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, Haleon has a consensus rating of “Moderate Buy” and an average price target of $12.33.

Haleon Stock Performance

Haleon stock opened at $10.45 on Wednesday. The stock has a fifty day moving average price of $9.86 and a 200 day moving average price of $9.61. Haleon has a 52 week low of $8.71 and a 52 week high of $11.42. The firm has a market capitalization of $46.51 billion, a P/E ratio of 26.78 and a beta of 0.19. The company has a current ratio of 0.87, a quick ratio of 0.63 and a debt-to-equity ratio of 0.48.

Institutional Investors Weigh In On Haleon

Institutional investors have recently modified their holdings of the stock. Bank of America Corp DE lifted its position in shares of Haleon by 116.7% during the second quarter. Bank of America Corp DE now owns 12,384,135 shares of the company’s stock worth $128,423,000 after purchasing an additional 6,669,923 shares during the last quarter. Acadian Asset Management LLC increased its holdings in Haleon by 3,031.5% in the second quarter. Acadian Asset Management LLC now owns 5,384,661 shares of the company’s stock valued at $55,813,000 after buying an additional 5,212,711 shares during the last quarter. Optiver Holding B.V. acquired a new stake in Haleon during the third quarter valued at approximately $45,593,000. JPMorgan Chase & Co. lifted its holdings in Haleon by 36.6% during the 3rd quarter. JPMorgan Chase & Co. now owns 11,984,672 shares of the company’s stock worth $107,503,000 after buying an additional 3,207,986 shares during the last quarter. Finally, ABC Arbitrage SA lifted its holdings in Haleon by 159.4% during the 3rd quarter. ABC Arbitrage SA now owns 2,727,350 shares of the company’s stock worth $24,464,000 after buying an additional 1,675,889 shares during the last quarter. Institutional investors and hedge funds own 6.67% of the company’s stock.

Haleon Company Profile

Haleon plc (NYSE:HLN) is a global consumer healthcare company formed through the separation of a large pharmaceutical group’s consumer health business in 2022. Headquartered in the United Kingdom, Haleon develops, manufactures and markets a broad portfolio of over‑the‑counter medicines, oral health products, vitamins, minerals and supplements, and other consumer health goods designed for daily self‑care and symptom relief.

The company’s product mix spans categories such as oral care (toothpastes and sensitivity treatments), pain relief and analgesics, respiratory remedies, digestive health products, topical treatments and nutritional supplements.